Melisa Antoniolli

Melisa Antoniolli

Auto-generated profile, based on publicly available information

Melisa Antoniolli

SAC Joven

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 June 2023 in Revista Peruana de Medicina Experimental Y Salud Pública
Verified
Journal Article
Open access
PDF file
SGSebastian Garcia-Zamora
Sebastian Garcia-Zamora
PIPablo A. Iomini
Pablo A. Iomini
LPLaura Pulido
Laura Pulido
AMAndrés F. Miranda-Arboleda
Andrés F. Miranda-Arboleda
PSPilar Lopez Santi
Pilar Lopez Santi
ABAdrian Marco Baranchuk
Adrian Marco Baranchuk
Objetivos. Explorar la frecuencia e impacto de la violencia contra los trabajadores de salud de Argentina y compararlo con el resto de sus pares de Latinoamérica en el contexto de la pandemia por COVID-19. Materiales y métodos. Estudio de corte transversal a través de una encuesta electrónica al personal médico y no médico de Latinoamérica que desempeño tareas asistenciales desde marzo de 2020. Se utilizó una regresión de Poisson para estimar las Razones de Prevalencia crudas (RP) y ajustadas (RPa) con sus respectivos intervalos de confianza al 95%. Resultados. Un total de 3544 participantes de 19 países respondieron la encuesta; 1992 (56,0%) residían en Argentina. Entre los mismos, el 62,9% padeció al menos un hecho de violencia: 97,7% refirió violencia verbal y 11,8% violencia física. El 41,5% de los agredidos padecieron situaciones de violencia al menos una vez por semana. El personal de salud de Argentina vivenció más frecuentemente violencia que los de otros países (62,9% vs. 54,6%, p<0,001), siendo estos eventos más habituales y estresantes (p<0,05). Además, refirieron más frecuentemente haber considerado cambiar sus tareas asistenciales y/o deseos de abandonar su profesión (p<0,001). En la regresión de Poisson, los participantes deArgentina tuvieron una prevalencia de violencia mayor que los trabajadores de salud de la región (14,6%; p<0,001). Conclusiones. Existió una elevada prevalencia de violencia contra el personal de salud de Argentina durante la pandemia por COVID-19. Estos hechos tuvieron un alto impacto negativo entre quienes los padecieron. Nuestros datos sugieren que, esto podría haber sido más frecuente en Argentina respecto de otras regiones del continente.

28 October 2021
Verified
Journal Article
Closed access
ASAlan Rodrigo Sigal
Alan Rodrigo Sigal
MAMelisa Antoniolli
Melisa Antoniolli
PSPilar Lopez Santi
Pilar Lopez Santi
NANicolás Aquino
Nicolás Aquino
ELEzequiel Lerech
Ezequiel Lerech
FBFernando Botto
Fernando Botto

21 May 2026 in Revista Argentina de Cardiologia
Verified
Journal Article
Open access
PDF file
LCLeonardo Caceres
Leonardo Caceres
MAMelisa Antoniolli
Melisa Antoniolli
MKMaribel Kanchi
Maribel Kanchi
GMGuillermo Mazo
Guillermo Mazo
GSGisela Streintenberger
Gisela Streintenberger
GGGustavo Giunta
Gustavo Giunta
Background: Hypertrophic cardiomyopathy (HCM) is the most common genetic heart disease, exhibiting a wide range of clinical presentations, from asymptomatic forms to advanced heart failure and sudden cardiac death. Although therapeutic strategies have improved outcomes, most patients are still managed in non-specialized centers with variable access to advanced diagnostic tests and a lack of a standardized approach. Objectives: To describe clinical practice and access to diagnostic tests for patients with HCM in non-specialized centers in Argentina. Methods: We conducted a nationwide, retrospective, multicenter and observational study. Patients > 18 years with a confirmed or highly probable diagnosis of HCM, followed up by cardiologists at outpatient clinics of non-specialized centers were included. Cases with secondary hypertrophy were excluded. Data were collected on the REDCap platform of the Argentine Society of Cardiology between June 1, 2023, and September 1, 2024. Results: A total of 160 patients from 8 provinces were included (mean age 48 years; 60.6% men). The most common cardiovascular risk factors were hypertension (46.7%) and dyslipidemia (31.4%). The most common reason for consultation was a presumptive or confirmed diagnosis of HCM (43.4%), followed by symptoms such as dyspnea and angina. Echocardiography was performed in 97.5% of cases, cardiac magnetic resonance imaging (CMRI) in 60%, and genetic testing in 40%. Among patients who underwent genetic testing, the diagnostic yield was 82.8%, with a predominance of variants in sarcomere genes MYH7 and MYBPC3. Left ventricular outflow tract obstruction was present in 34.3% of patients, and late gadolinium enhancement was observed in 81.2% of those evaluated by CMRI. Most patients received beta-blockers, and a subgroup required interventions, including 26 implantable cardioverter-defibrillator implantations and 4 septal myectomy procedures. Conclusions: This first Argentine registry of HCM in non-specialized centers reveals significant differences in the use of ancillary tests and implementation of therapeutic strategies. These findings evidence the presence of inequities in access to diagnostic resources and care pathways, underscoring the need to strengthen medical education, develop referral networks, and adapt international guidelines to the local context to optimize the diagnosis and management of this disease.

31 October 2021 in Revista Argentina de Cardiologia
Verified
Journal Article
Open access
ASAlan R. Sigal
Alan R. Sigal
MAMelisa Antoniolli
Melisa Antoniolli
PSPilar Lopez Santi
Pilar Lopez Santi
NANicolás Aquino
Nicolás Aquino
ELEzequiel Lerech
Ezequiel Lerech
FBFernando Botto
Fernando Botto
Background: The correct management of lipid-lowering treatment is one of the key factors for the reduction of cardiovascular risk in secondary prevention patients. High-dose statins, ezetimibe, and more recently PCSK9 inhibitors (PCSK9i) are the main tools available to meet LDL cholesterol (LDL-C) therapeutic goals in these patients. Despite the overwhelming evidence in their favor, these therapies are greatly underutilized worldwide, with low levels of adherence and therapeutic inertia. In Argentina, there is scarce evidence on the quality of lipid-lowering treatment and the rate of patients in secondary prevention with a controlled lipid profile according to national and international guidelines. Methods: A prospective, multicenter, cross-sectional study including consecutive patients in secondary prevention for cardiovascular events from hospitals of Argentina with a Medical Residency system affiliated to CONAREC, was carried out from March to August 2020. Data was collected on the lipid-lowering treatment received, the reasons behind the non-use of statins in adequate doses and the lipid profile levels in case of having a record from the last 6 months prior to inclusion. Results: Among 1000 consecutive patients included from 24 centers corresponding to 11 provinces, 85.9% was treated with statins, 4.8% with ezetimibe, 2.4% with fibrates, and 13% was without treatment. In the case of patients treated with statin therapy, 67% was receiving high-dose statins (58% of the total number of patients). A total of 509 patients presented LDL-C assessment within the last 6 months. Mean LDL-C was 94 (90.6-97.8) mg/dl, HDL cholesterol 41 (40.7-42.6) mg/dl, and triglycerides 151 (142.9-159.8) mg/dl. In 30% of cases, LDL-C was below the cut-off value of 70 mg/dl and in 16% below 55 mg/ dl. In 37% of patients, LDL-C was >100 mg/dl. Conclusions: In this multicenter secondary prevention study performed in Argentina, just over half of the patients presented high-dose statin treatment, with scarce use of ezetimibe. Undertreatment was reflected in LDL-C values, with more than two-thirds of patients outside the therapeutic range, and therefore far from clinical guideline recommendations. How to cite this article: Sigal AR, Antoniolli M, López Santi P, Aquino N, Lerech E, Botto F, et al. Use of Lipid-Lowering Agents and Therapeutic Goal Achievement in Cardiovascular High-Risk Patients in Argentina. Rev Argent Cardiol 2021;89:373-383 http://dx.doi.org/10.7775/rac.v89.i5.20409

21 April 2026
Verified
Journal Article
Closed access
LCLeonardo Cáceres
Leonardo Cáceres
MAMelisa Antoniolli
Melisa Antoniolli
MKMaribel Kanchi
Maribel Kanchi
GMGuillermo Mazo
Guillermo Mazo
GSGisela Streintenberger
Gisela Streintenberger
GGGustavo Giunta
Gustavo Giunta

3 February 2026 in Revista Argentina de Cardiologia
Verified
Journal Article
Open access
PDF file
DCDiego Crippa
Diego Crippa
GTGiuliana A. Tresenza
Giuliana A. Tresenza
MAMelisa Antonioili
Melisa Antonioili
ELEzequiel D. Lerech
Ezequiel D. Lerech
JGJuan Gagliardi
Juan Gagliardi
HIHeraldo A. D` Imperio
Heraldo A. D` Imperio
Background: Delirium is a common and potentially preventable complication in the postoperative period following cardiovascular surgery (CVS). Its onset is associated with poorer clinical outcomes, such as longer hospital length of stay and higher mortality.Internationally, delirium in the postoperative context of cardiovascular surgery has been extensively studied in multicenter cohorts and observational studies, with varying prevalences. In Argentina, we have previous registries of CVS, but despite this, this complication has not been explored in depth. Objective: The aim of this study was to analyze the incidence of postoperative delirium following CVS and to identify predictors thatcontribute to its development.Methods: We conducted an analysis of the Argentine National Registry of Cardiovascular Surgery (ARGEN-CCV), a cross-sectional, multicenter study spanning 13 months from July 2021 to August 2022. Patients were recruited from 48 public and private cent-ers. Data from consecutive patients aged 18 years or older admitted for central CVS were analyzed. Surgeries for congenital heart defects and peripheral vascular surgery were excluded from the registry. The diagnosis of delirium was based on clinical assessment. Univariate and multivariate analyses were performed to define independent predictors of delirium onset.Results: A total of 1515 patients were included in the analysis with an incidence of delirium of 9.1%. Patients with delirium wereolder (68 vs. 64 years, p<0.001) and had a higher prevalence of chronic obstructive pulmonary disease (COPD), alcoholism, and frailty, as well as a higher incidence of postoperative atrial fibrillation (AF). On multivariate analysis, coronary artery disease (OR1.64; 95% CI: 1.02–2.64; p=0.041), postoperative sepsis (OR 3.13; 95% CI: 1.65–5.96; p<0.001), postoperative AF (OR 2.07; 95% CI: 1.29–3.32; p=0.003), and prolonged mechanical ventilation (OR 2.86; 95% CI 1.68–4.86; p<0.001), were identified as independent predictors of delirium, while frailty showed a trend (OR 2.16; p=0.068). A predictive model was constructed using these variables,which demonstrated good discrimination, with an area under the curve (AUC) of 0.76 (95% CI: 0.71–0.80) and excellent calibration (Hosmer-Lemeshow test with p value = 0.999).Conclusions: Postoperative delirium occurs in 9.1% of patients undergoing cardiovascular surgery in our series. Coronary arterydisease, postoperative AF, and prolonged MV were identified as predictors for the development of delirium.